loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for AM20040094

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    AM20040094

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 161Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ajanta Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.
    Ajanta Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.

    23 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217659

    FDA
    23 Feb 2024
    Share Share
    Medley Pharma's Generic Oxcarbazepine Receives Approval in the U.S.
    Medley Pharma's Generic Oxcarbazepine Receives Approval in the U.S.

    14 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217782

    FDA
    14 Feb 2024
    Share Share
    USFDA gives final nod to Zydus’ tablets for treatment of seizures
    USFDA gives final nod to Zydus’ tablets for treatment of seizures

    04 Jul 2023

    // FINANCIAL EXPRESS

    https://www.financialexpress.com/healthcare/pharma-healthcare/usfda-gives-final-nod-to-zydus-tablets-for-treatment-of-seizures/3154959/

    FINANCIAL EXPRESS
    04 Jul 2023
    Share Share
    Zydus' Generic Oxcarbazepine Receives Approval in the U.S.
    Zydus' Generic Oxcarbazepine Receives Approval in the U.S.

    03 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211747

    FDA
    03 Jul 2023
    Share Share
    Enforcement Report - Week of June 7, 2023
    Enforcement Report - Week of June 7, 2023

    07 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

    FDA
    07 Jun 2023
    Share Share
    Enforcement Report - Week of December 28, 2022
    Enforcement Report - Week of December 28, 2022

    28 Dec 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-28-2022-95999.pdf

    FDA
    28 Dec 2022
    Share Share